SEC: Trading scheme involved confidential government information

The Securities and Exchange Commission has announced alleged insider-trading charges in a plot that used non-public government information to affect the value of publicly traded medical stocks.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.